INTRODUCTION
The PI3K signaling pathway has a critical role in controlling cellular growth, survival and proliferation. Indeed, if PI3K activity is not tightly regulated this can result in cancer, autoimmunity or inflammatory disease. 1, 2 In immune cells, the SH2-domaincontaining inositol phosphatase SHIP-1 is one of two major negative regulators of PI3K activity. 3 SHIP-1 exerts its function by dephosphorylating and thus removing the key signaling intermediate PI (3, 4, 5 )P 3 by converting it to PI(3,4)P 2 . Although SHIP-1 in most instances inhibits PI3K signaling, recent studies have found that in some contexts SHIP-1 can also promote or amplify PI3K signals that trigger cell differentiation 4 or the survival of cancer cells through production of PI(3,4)P 2 5 SHIP-1 is predominantly expressed in hematopoietic cells and its importance in regulation of immune cell activation is exemplified by the varied phenotypes observed in SHIP-1 À / À mice. SHIP-1-deficient mice were first described in the late 1990s and were found to exhibit a myeloproliferative disorder leading to splenomegaly, lymphadenopathy and widespread myeloid infiltration into vital organs. 6, 7 They displayed early mortality attributed to the extensive consolidation of lungs from infiltration by myeloid cells. 6, 7 Later studies demonstrated that the inflammatory lung disease was driven by the hematopoietic compartment, as lethally irradiated SHIP-1 À / À mice transplanted with SHIP-1 þ / þ bone marrow were rescued from lung inflammation and early lethality. 8 It was also shown that lung consolidation could be triggered by induction of SHIP-1 deficiency in adult mice. 5 SHIP-1-deficient mice show a dramatic expansion of splenic myeloid progenitors, 6, 9 and there appears to be a direct correlation between myeloid progenitor expansion and development of lung inflammation. 10 In more recent studies, the lung disease phenotype has been accredited to macrophage activation and the presence of alternatively activated 'M2' macrophages infiltrating the lungs.
11 SHIP-1-deficient macrophages were found to possess constitutively high arginase-1 and Ym1 (prototypic M2 markers) with coincident reduction in the M1 marker nitric oxide, and the lungs of the mice exhibited abundant chitinase crystals produced by M2 macrophages. 11 Thus until recently, the working hypothesis has been that macrophages within SHIP-1 À / À mice are spontaneously M2-programmed and that this contributes to the lung pathology and shortened lifespan.
This hypothesis has been questioned recently by the observation that SHIP-1-deficient mice on the BALB/c genetic background, which is conventionally thought to be Th2-prone and M2-skewed, 12 are completely protected from developing lung inflammation, although they develop a lung phenotype late in life that is thought to be secondary to the development of autoimmune disease. 10 Absent from BALB/c SHIP-1 À / À mice are the traits typical of mixed genetic background or C57BL/6 SHIP-1 À / À mice such as splenomegaly, myeloid progenitor expansion, elevated inflammatory cytokines and macrophagerich lung inflammation. 10 We have recently found that the lungs of susceptible C57BL/6 SHIP-1-deficient mice, but not resistant BALB/c SHIP-1 macrophages that are distinguished by expression of Mac-1. 13 Normal alveolar macrophages (AMFs) are homogenous CD11c þ Mac-1 À cells; however, approximately half of the macrophages in the lungs of C57BL/6 SHIP-1-deficient mice are CD11c þ Mac-1 þ and they have an enlarged, vacuolated and activated appearance. 13 They have been found to produce both M1 and M2 factors and to express very high levels of matrix metalloproteinase 12, an elastolytic enzyme that is almost certainly responsible for the emphysematous phenotype of SHIP-1 À / À lungs. 13 It has now been shown that myeloid inflammation also afflicts the small intestine of SHIP-1-deficient mice. 14, 15 The mice develop a disease that resembles Crohn's disease (CD) and it is largely confined to the distal portion of the small intestine known as the ileum. Flow cytometry and histopathology show that this inflammation is myeloid cell-rich and features extensive coexistent fibrosis, thought to be driven by arginase-1. 14, 15 Similar to the inflammatory lung phenotype, gut inflammation is driven by the hematopoietic compartment since reconstitution of SHIP-1 À / À mice with SHIP-1-sufficient bone marrow was able to reverse disease, and conversely, reconstitution of control mice with SHIP-1 À / À splenocytes was able to transfer ileitis. 14 An intriguing finding was the paucity of CD4 þ and CD8 þ T cells in the lamina propria of the small intestine, suggesting that SHIP-1 deficiency may lead to a lack of effector T cells in the small intestine, and thus an inability to control the activation of hyperresponsive SHIP-1-deficient myeloid cells. 14 Given the purported central role of myeloid cells in the inflammatory lung and gut phenotypes of SHIP-deficient mice, we have now asked whether deficiency of SHIP-1 solely in the myeloid compartment would recapitulate the inflammatory phenotype. Unlike mice carrying germline null mutations in SHIP-1, SHIP-1 DMyeloid mice and LysCreSHIP flox/flox mice, both harboring myeloid-restricted deletion of SHIP-1, had ostensibly normal lungs and gut with no evidence of macrophage or neutrophil infiltration and activation. In addition, splenomegaly and myeloid progenitor defects characteristic of germline SHIP-1 deficiency were largely absent from SHIP-1 DMyeloid mice. These studies clearly show that mucosal inflammation in SHIP-1-deficient mice is driven by loss of SHIP-1 in multiple immune cell compartments and cannot solely be attributed to SHIP-1 deficiency in LysM-positive myeloid cells.
RESULTS

Conditional deletion of SHIP-1 in myeloid cells
To determine whether SHIP-1 deficiency in the myeloid compartment is the primary cause of mucosal inflammation in SHIP-1 À / À mice, we examined two previously described strains of mice with myeloid-restricted deletion of SHIP-1. 16, 17 One strain designated LysCreSHIP flox/flox , carries a myeloid-restricted deletion of the promoter and first coding exon of SHIP-1, 18 and previous studies have shown that peritoneal macrophages from these mice express no SHIP-1 protein. 19 The control for this strain is designated SHIP flox/flox . The other strain designated SHIP-1
DMyeloid
, carries a myeloid-restricted mutation in SHIP-1 removing sequences encoded by exons 11-12, and previous studies showed that SHIP-1 is not expressed at all in splenic macrophages from these mice. 16 The control for this strain is designated SHIP
FLOX
. As this second model carries an internal deletion in SHIP-1, and expression of a non-functional truncated SHIP-1 protein has been found upon conditional deletion in some cell lineages, 10 we examined SHIP-1 expression in AMFs to assess a different subpopulation of macrophages. Unlike splenic macrophages, 16 AMFs of SHIP-1 DMyeloid mice expressed abundant truncated SHIP-1 protein (SHIPtrn; Figure 1 ). In keeping with the high efficiency of Cre-mediated excision from the LysM promoter in AMFs, 20 close to 100% of the SHIP-1 protein was in the truncated form ( Figure 1 ).
In previous studies we have assessed the 5 0 phosphatase activity of this truncated SHIP-1 protein and showed that it was completely phosphatase-inactive. 10 In agreement with the expression of SHIPtrn in AMFs from SHIP-1 DMyeloid mice, AMFs from mice harboring a germline deletion of exons 11-12 of SHIP-1 (SHIP-1 NULL ) also expressed similar levels of the truncated SHIP-1 protein (Figure 1 ). Thus, this truncated, albeit phosphatase-inactive SHIP-1 protein, is more stable in AMFs than in splenic macrophages.
Myeloid-conditional deletion of SHIP-1 does not cause consolidating pneumonia SHIP-1 À / À mice have a shortened lifespan, with consolidating eosinophilic crystalline pneumonia being the likely primary cause of death. 6, 7 We observed that SHIP-1 DMyeloid mice had markedly improved median survival (512 days) when compared with SHIP-1 À / À mice, whereas SHIP-1 NULL mice harboring germline deletion of exons 11-12 had significantly poorer survival (Figure 2a) . The reduced survival of SHIP-1 NULL mice over that of SHIP-1 À / À mice is in keeping with the poor survival of SHIP-1 el20/el20 mice, which carry an ENU-induced mutation in SHIP-1 that renders the protein phosphatase-inactive. 21 Similar to SHIP-1 DMyeloid mice, LysCreSHIP-1 flox/flox mice also exhibited an essentially normal lifespan with the median survival 4400 days (data not shown). Lungs of mice harboring myeloid-restricted deletion of SHIP-1 (SHIP-1
DMyeloid and LysCreSHIP-1 flox/flox mice) did not develop consolidating eosinophilic crystalline pneumonia, which in contrast developed at an early age in lungs of SHIP-1 
mice is comprised of increased numbers of activated AMFs. 13 We found that the BAL of SHIP-1
DMyeloid mice was composed of normal numbers of AMFs with a quiescent appearance, in comparison to that of SHIP-1 NULL and SHIP-1 À / À mice that had greatly increased numbers of enlarged, activated AMFs (Figures 2d and e) . Analysis of H&E sections of the lungs of LysCreSHIP flox/flox mice indicated that this second model of myeloid-specific SHIP-1 deletion also contained AMFs of normal appearance. We have previously found that SHIP-1 À / À mice have elevated levels of the pro-inflammatory cytokines interleukin (IL)-4, IL-5, IL-6 and granulocyte colony-stimulating factor (G-CSF) in BALF; 10 however, measurement of these cytokines in the BALF of SHIP-1 DMyeloid mice revealed no differences to control mice ( Figure 2f ). Collectively, these data demonstrate that loss of SHIP-1 in LysM-positive myeloid lineage cells is not sufficient to induce severe inflammatory lung disease. DMyeloid and SHIP-1 À / À samples for IL-6 and G-CSF were analyzed by t-test; *Po0.05.
Transmural ileitis is absent in mice lacking SHIP-1 in myeloid cells As germ-line loss of SHIP-1 results in CD-like ileitis, characterized by marked, mixed, transmural inflammatory cell infiltrations that extend by way of fissures through the ileum serosa into the mesentery, 14, 15 the small intestines of young 10-to 20-week-old mice were then examined. Consistent with the disease having a high penetrance, 14 4/4 C57BL/6 background SHIP-1 À / À mice had segmental ileitis with marked leukocyte infiltrates extending into the tunica muscularis ( Figure 3a) and a mean inflammatory score of 5.3 ± 1.0. In keeping with their inflammatory lung disease phenotype, 10/13 SHIP NULL mice also exhibited myeloid-rich, segmental ileitis that extended into the tunica muscularis (Figure 3a) with a mean score of 2.8 ± 2.0. In contrast, intestines of 10/11 SHIP-1 DMyeloid mice had no significant abnormalities; mean score 0.2±0.6 (Figure 3b ), similar to the control SHIP FLOX mice where 9/10 control mice also had no significant abnormalities; mean score 0.2 ± 0.6. Consistent with the analysis of SHIP-1 DMyeloid mice, segmental, transmural ileitis was also absent from LysCreSHIP flox/flox mice, and did not develop in more than 1-year-old mice. Intestines of 7/9 LysCreSHIP flox/flox mice 412 months old showed no significant abnormalities; mean score 0.2 ± 0.4 ( Figure 3b ). In a minority of each model of myeloid-specific SHIP-1 deletion (1/11 SHIP DMyeloid and 2/9 LysCreSHIP flox/flox mice), o25 neutrophils high power field (hpf) were rarely, focally present in the lamina propria or submucosa overlaying lymph nodules equating to CD grade 1 (Figure 3c) . This rare, mild grade 1 inflammatory cell infiltration observed occasionally in mice lacking SHIP-1 in myeloid cells is in stark contrast to the marked, mixed inflammatory cell infiltrations that extended deep into the tunica muscularis of germ-line SHIP-1 (Figure 3a ). 14 Thus, in two independent models of myeloid-specific SHIP-1 deletion, loss of SHIP-1 in LysM-positive myeloid lineage cells is not sufficient to recapitulate either the segmental ileitis or the consolidating pneumonia characteristic of germline SHIP-1 deficiency. 10, 14 Splenomegaly and myeloid expansion in SHIP-1 À / À mice is only partly due to loss of SHIP-1 in myeloid cells SHIP-1 À / À mice develop splenomegaly due to the expansion of myeloid and erythroid cells and a substantial elevation in hematopoietic progenitors. 6, 9, 10 Using SHIP-1 DMyeloid mice we examined whether this was intrinsic to loss of SHIP-1 in the myeloid compartment. A 1.5-fold increase in spleen weight was observed in 8-to 12-week-old SHIP-1
DMyeloid mice when compared with controls; however, this phenotype was significantly less than the 3.4-fold increase associated with germ-line deletion of SHIP-1 in SHIP-1 À / À or SHIP NULL mice (Figure 4a ). Although proportions of Mac-1 þ cells per spleen remained normal, absolute numbers were increased 1.4-fold, consequent to the enlargement of the spleen and an overall increase in spleen cellularity (Figures 4b and c) . This small but nonsignificant increase is likely in part to represent the increase in myeloid-derived suppressor cells we have described in LysCreSHIP flox/flox mice. 17 Despite this slight expansion of myeloid cells in SHIP-1 DMyeloid mice, splenic myeloid progenitors were not increased, being significantly lower than those seen in the SHIP-1 À / À spleen (Figure 4d) . Thus, the enhanced myelopoiesis in SHIP-1 À / À mice is not mediated exclusively by loss of SHIP-1 in LysM-positive myeloid cells but is dependent on other factors.
The B-cell compartment is largely unaltered in SHIP-1 DMyeloid mice
We next analyzed the B-cell compartment, finding that proportions of splenic B cells and plasma cells were unchanged in SHIP DMyeloid mice (Figure 5a ). Although follicular B cells were found in normal proportions, the increased weight and cellularity of SHIP DMyeloid spleens resulted in a nonsignificant 1.3-fold increase in total number (Figures 5b and c) . It has been reported previously that splenic B-cell organization is disrupted in SHIP-1 DMyeloid mice, with the marginal zone population being unable to localize correctly due to loss of marginal zone macrophages. 16 Despite this, no significant change in marginal zone B-cell numbers in 10-week-old mice were observed DMyeloid and LysCreSHIP flox/flox mice, some aged 412 months, only o25 neutrophils per hpf (arrows) were rarely, focally present in the lamina propria or submucosa of the ileum, with no evidence of progression to segmental transmural ileitis ( Â 630 bottom, Â 100 top, scale bar denotes 100 mm).
( Figures 5b and c) , although a 50% deficit did manifest when mice were aged 20 weeks (not shown). As the B-cell populations were slightly affected by the myeloid-specific loss of SHIP-1, we analyzed levels of serum immunoglobulin. Interestingly, all serum Ig levels were normal with the exception of IgG3 (Figure 5d ). It is known that marginal zone B cells produce IgG3; 22 therefore, this may suggest impaired marginal zone B-cell antibody production.
DISCUSSION
Global disruption of SHIP-1 leads to a plethora of phenotypes, many of which are centered around the myeloid compartment, although significant B-cell, NK cell and T-cell defects have also been described (reviewed in Kerr 3 ). The phenotypes have been attributed to hematopoietic cell hyperactivation caused by loss of inhibitory signaling pathways controlled by SHIP-1, [23] [24] [25] [26] [27] or in some cases, to hyporesponsiveness by key immune cells (for example, NK cells). 18, 28 Although SHIP-1 À / À mice have proven useful for elucidating roles for SHIP-1 in various immune cell functions, it has been difficult to separate the cell-intrinsic effects of loss of SHIP-1 from those caused by secondary responses to the heightened inflammatory environment and/or aberrant cytokine production. Conditional deletion of SHIP-1 is proving invaluable for defining the roles of SHIP-1 in numerous hematopoietic lineages. In this study, we have asked whether SHIP-1 deletion specifically in myeloid cells is responsible for the susceptibility of SHIP-1-deficient mice to chronic inflammatory disease. Initially, it was reasonable to assume that macrophages had a central role in the inflammatory lung disease of SHIP-1-deficient mice, as the lungs of mice, even at an early age, were consolidated with activated macrophages. 6, 7, 29 Furthermore, when examined in vitro, SHIP-1 À / À macrophages were found to be hyperresponsive to growth factor stimulation. [30] [31] [32] Moreover, loss of SHIP-1 gave rise to a dramatic expansion in hyper-responsive myeloid progenitors 6, 9 leading to myeloid expansion in primary and secondary lymphoid tissue and blood, and the seeding of myeloid cells in favorable sites such as the lung, which is rich in granulocyte-macrophage colony-stimulating factor. 33, 34 Further studies suggested that the lung phenotype was due to the spontaneous generation of alternatively activated M2-skewed macrophages leading to the deposition of macrophage-derived eosinophilic chitinase crystals. 11 Recent studies however have challenged the M2 designation of the lung inflammation in SHIP-1 À / À mice with the finding that BALB/c background SHIP-1 À / À mice are resistant to eosinophilic pneumonitis, suggesting that severe inflammatory disease must occur in the context of a permissive genetic background. 10 Furthermore, instead of global M2 macrophage polarization in SHIP-1 À / À lungs, macrophage subpopulation deregulation and upregulation of both M1 and M2 markers was observed. 13 We now show that conditional deletion of SHIP-1 in myeloid cells does not result in inflammatory lung disease or myeloproliferative disease typical of global loss of SHIP-1. Phenotypes characteristic of mice harboring germ-line mutations in SHIP-1 including increased numbers of activated AMFs and elevated levels of growth factors and proinflammatory cytokines in the lung were absent, showing that they are not intrinsic to loss of SHIP-1 in macrophages. Although myeloid-conditional deletion of SHIP-1 resulted in mild splenomegaly and a slight expansion of myeloid cells, these phenotypes were minor when compared with those of SHIP-1 À / À mice. Furthermore, the enhanced splenic myelopoiesis characteristic of SHIP-1-deficient animals was not reproduced by myeloid-conditional SHIP-1 deletion. Thus, the myeloproliferative phenotype of SHIP-1-deficient mice is less dependent on intrinsic loss of SHIP-1 in LysM-positive myeloid cells, with loss of SHIP-1 in other cell lineages clearly required for fully penetrant disease.
It is clear that germ-line SHIP-1 deficiency in mice results in a myeloproliferative disease that affects not only the lung but also other organs including the kidney and liver. 7 Recent studies have shown that a granulocyte-rich inflammation also afflicts the small intestine of SHIP-1 À / À mice leading to a CD-like ileitis. 14,15 It appears likely that the disease process that induces pulmonary inflammation also gives rise to myeloproliferation in the ileum, although the inflammatory cell makeup is of a slightly different nature. In consolidated lungs of SHIP-1 À / À mice the predominant cell type is the macrophage, 10, 13 whereas the inflammation in the ileum is principally granulocytic.
14,15 IL-6 is likely to have some role in shaping the inflammatory response and myeloproliferative phenotype of SHIP-1 À / À mice. Chronic elevation of IL-6 can induce myeloproliferative disease 35 and its levels are elevated in SHIP-1 À / À serum. 10, 11, 25, 36 Further, IL-6 can cooperate with other growth factors to promote hematopoiesis 37, 38 and it has been shown to skew hematopoiesis toward myeloid cell production in SHIP-1-deficient mice. 36, 39 Nonetheless, in unpublished studies we have found that loss of IL-6 on a SHIP-1-deficient background did not resolve lung inflammation. Other myeloid growth factors including G-CSF and granulocyte-macrophage colony-stimulating factor are also elevated in the serum of SHIP-1 À / À mice 10,40 and may contribute to the myeloproliferative disease process. G-CSF, for example, is the most commonly used agent for mobilization of hematopoietic stem cells 41 and its high circulating levels in SHIP-1 À / À mice may help to explain the increased numbers of hematopoietic stem cells 42 and myeloid progenitors 9 that reside outside of their bone marrow. Key questions remaining are whether these factors are causal or consequential to disease, what triggers their production in a permissive genetic background and how SHIP-1 ordinarily regulates this process.
The SHIP-1 gene (inpp5d) is not only expressed as a 145-kDa protein but can also be expressed as multiple isoforms, including a shorter, 100-kDa isoform, s-SHIP, which derives from a separate internal promoter. 43 s-SHIP is thought to be primarily expressed in stem cells 43 but has also been identified in other hematopoietic cell types, 21 and retains the phosphatase domain but lacks the N-terminal SH2 domain, suggesting a different signaling function to full-length SHIP-1. 43 Depending on the genetic strategy used to generate a SHIP-1 deletion, some strains of SHIP-1-deficient mice retain s-SHIP expression, including the SHIP-1 À / À mice 23 and the LysCreSHIP flox/flox mice 17 used in this study. However, in the SHIP DMyeloid and SHIP NULL models-SHIP-1 and s-SHIP-are mutated, rendering them phosphatase-inactive. Herein, we have utilized two different models of myeloid conditional inactivation of SHIP-1 to unequivocally demonstrate that mucosal inflammation is not initiated by the myeloid compartment of SHIP-1-deficient mice and that s-SHIP sufficiency does not protect from these inflammatory diseases.
While we have shown that loss of SHIP-1 in LysM-positive myeloid cells does not initiate lung and gut disease, it is clear that in a specific environment, SHIP-1-deficient myeloid cells are conscripted into the disease process, whereby they contribute to its severity through the production of inflammatory mediators and proteolytic enzymes that can exacerbate inflammation and cause tissue destruction and fibrosis. It remains to determine the initial triggering event that promotes the destructive inflammatory process in SHIP-1-deficient mice. Interestingly, BALB/c and C57BL/ 6 background SHIP-1 À / À mice display differential susceptibility to myeloproliferative disease, 10 and by virtue of their different backgrounds, express clear genetic differences in their T-cell compartments. The lung disease present in C57BL/6 SHIP-1 À / À mice may well be initiated or promoted by respiratory pathogen encounter or perhaps even responses to commensal organisms at mucosal sites, leading to an over-exuberant Th1 immune response in C57BL/6 SHIP-1 À / À mice that is genetically suppressed in BALB/c SHIP-1 À / À mice due to their Th2-dominant background. In support of this, previous studies have shown that mixed genetic background SHIP-1 À / À mice are hyperresponsive to lipopolysaccharide. 31 Furthermore, mice exhibiting T-cell-specific loss of SHIP-1 are skewed towards Th1 responses 44 and, moreover, SHIP-1-deficient mice develop a polarized non-protective Th1 response during helminth infection. 19 However, we have recently shown that reconstitution of lethally irradiated C57BL/6 hosts with SHIP-1-deficient bone marrow gives rise to a granulomatous lung disease rather than severe pneumonitis traditionally associated with germ-line SHIP-1 deficiency. 13 As it is well known that a subset of radiation-resistant T cells survive lethal irradiation, 45 this suggests that the presence of a small proportion of host-derived SHIP-1-sufficient T cells is able to limit lung disease. Future studies need to be directed at defining the precise cellular and molecular basis for the chronic myeloproliferative phenotype in SHIP-1-deficient mice and whether disease is driven by an overactive myeloid compartment that cannot be suppressed in the presence of SHIP-1-deficient T cells.
MATERIALS AND METHODS Animals
To generate myeloid cell-conditional deletion of SHIP-1, we used two independently derived and previously published strains of floxed SHIP-1 mice, 16, 18 which were crossed to LysM-Cre-transgenic mice. 20 One strain is designated SHIP-1 DMyeloid 16 and was used alongside SHIP FLOX controls, whereas the second strain is identified as LysCreSHIP flox/flox , 18 with its control strain being SHIP flox/flox . SHIP-1-deficient mice, 23 backcrossed to the C57BL/6 background, 10 were also used as controls (designated as SHIP-1 À / À ), and in some studies we also used mice with a germ-line 
BAL and cytospins
Lungs from terminally anesthetized mice were lavaged with 400-ml phosphate-buffered saline, followed by three lavages of 300 ml. Cells were counted, centrifuged onto a glass slide (Shandon cytospin, Thermo Fisher Scientific, Scoresby, Victoria, Australia), and stained with DiffQuick. The BALF was centrifuged to pellet cells, and the supernatant was retained for cytokine measurement.
Western blots BAL cells were lysed at 1 Â 10 7 ml À 1 in 1% Triton X-100, 10 mM Tris pH 7.5, 150 mM NaCl, 50 mM NaF, 2 mM EDTA and protease inhibitor cocktail (Roche Diagnostics, Castle Hill, New South Wales, Australia). Clarified lysates, collected following centrifugation at 13 000 r.p.m. for 10 min, were reduced, separated on 7% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and then transferred to polyvinylidene difluoride membrane. Blots were probed with rabbit antibodies against SHIP-1 that were produced by immunizing rabbits with a glutathione-S-transferase fusion protein containing residues 953-1122 of mouse SHIP-1. Fluorescenceconjugated secondary antibodies were used (LI-COR Biosciences, Lincoln, NE, USA) and western blots were scanned using the Odyssey Infrared Imaging system (LI-COR Biosciences). The fluorescence signal was converted to greyscale for figures using the Odyssey Application software version 2.0.
Lung and gut histology
Lungs were inflation-fixed in 4% paraformaldehyde at 20-cm water pressure, then paraffin-embedded. In studies on aged SHIP-1 DMyeloid mice, collapsed lungs were analyzed. Swiss rolls of small intestines were fixed in 10% neutral-buffered formalin, then embedded in paraffin. Sections were stained with H&E, visualized using a Nikon BX61 microscope with Â 20 objective, and images were captured with a SPOT RT3 digital camera (Diagnostic Instruments, Sterling Heights, MI, USA). Intestinal inflammation was scored as described 14 using the following grading system: CD grade 1 indicates the rare focal presence of o25 neutrophils per hpf in the lamina propria or lymph nodule; CD grade 2 is 425 neutrophils per hpf in the lamina propria or lymph nodule; CD grade 3 is marked, mixed inflammatory cell infiltrations with extension below the muscularis mucosa causing architectural distortion of the mucosa and submucosa; CD grade 4 is extension of marked, mixed leukocyte infiltrations into the tunica muscularis; CD grade 5 is marked transmural leukocyte infiltrations; CD grade 6 represents extension of marked transmural leukocyte infiltrations into the mesentery and/or other organs.
Serum Ig isotypes
Serum Ig titers were measured with enzyme-linked immunosorbent assay using goat anti-mouse Ig (Southern Biotechnology Associates, Birmingham, AL, USA) as a capture antibody and a polyvalent goat anti-mouse horse radish peroxidase conjugated to the relevant specific isotype as a detection agent (Southern Biotechnology Associates).
Measurement of BALF cytokines
BALF cytokine levels were measured using a Bioplex Pro Multiplex Suspension Array system (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer's instructions. Beads coated with capture antibodies against IL-4, IL-5, IL-6 and G-CSF were used simultaneously in a multiplex assay.
Myeloid progenitor assay
Numbers of progenitors were determined in semisolid 0.3% agar cultures containing 100 000 spleen cells. Colony formation was stimulated by macrophage colony-stimulating factor (10 ng ml À 1 ), IL-3 (10 ng ml À 1 ), granulocyte-macrophage colony-stimulating factor (10 ng ml À 1 ), G-CSF (10 ng ml À 1 ) or stem cell factor (50 ng ml
; PeproTech, Rocky Hill, NJ, USA). Colonies (450 cells) were counted after 5-7 days in culture.
Statistics
For most studies, significance between groups was tested by one-way analysis of variance with Tukey's multiple comparison test using Graphpad Prism software 6.01 (Graphpad Software Inc., La Jolla, CA, USA). Some samples were analyzed by a non-parametric Student's t-test. The specific tests applied to each data set and the P-values obtained are in the figure legends.
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